Shinichiro Fuse
Login to view DISC.Shinichiro Fuse is a Partner at TPG where he co-leads the Life Sciences Innovations (LSI) fund, focusing on disruptive therapeutic companies. He leverages deep operational experience from prior roles, including founding SVP of Business Development at ElevateBio. He earned a Ph. D. in Microbiology and Immunology from Dartmouths Geisel School of Medicine.
He serves on the Board of Advisors for the Guarini School of Graduate and Advanced Studies at Dartmouth College and is also a columnist for Nikkei Biotech, a prominent biotech journal in Japan.
He was the interim CEO of Orna Therapeutics, a circular RNA company that was successfully acquired by Eli Lilly for up to $2. 4 billion.
Read the full overview →How Shinichiro shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Shinichiro cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other TPG Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.